Forefronts in Nephrology
Kidney International (2005) 68, 1932–1936; doi:10.1111/j.1523-1755.2005.00622.x
Stem cells and progenitor cells in renal disease
HERMANN HALLER, KIRSTEN DE GROOT, FERDINAND BAHLMANN, MARLIES ELGER and DANILO FLISER
Department of Nephrology, Hannover Medical School, Hannover, Germany
Correspondence: Hermann Haller, M.D., Professor of Medicine, Department of Nephrology, Medizinische Hochschule Hannover, Carl-Neuberg Strasse 1, Hannover, Germany. E-mail: Haller.Hermann@mh-hannover.de
Abstract
Stem cells and progenitor cells in renal tissue. Stem cells and progenitor cells are necessary for repair and regeneration of injured renal tissue. Infiltrating or resident stem cells can contribute to the replacement of lost or damaged tissue. However, the regulation of circulating progenitor cells is not well understood. We have analyzed the effects of erythropoietin on circulating progenitor cells and found that low levels of erythropoietin induce mobilization and differentiation of endothelial progenitor cells. In an animal model of 5/6 nephrectomy we could demonstrate that erythropoietin ameliorates tissue injury. Full regeneration of renal tissue demands the existence of stem cells and an adequate local "milieu," a so-called stem cell niche. We have previously described a stem cell niche in the kidneys of the dogfish, Squalus acanthus. Further analysis revealed that in the regenerating zone of the shark kidney, stem cells exist that can be induced by loss of renal tissue to form new glomeruli. Such animal models improve our understanding of stem cell behavior in the kidney and may eventually contribute to novel therapies.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Cell therapy for cardiovascular disease: what cells, what diseases and for whom?
Nature Clinical Practice Cardiovascular Medicine Review (01 Jan 2005)
NEWS AND VIEWS
Stem cells REGENT trial?the end of cell therapy for MI?
Nature Reviews Cardiology News and Views (01 Sep 2009)
RESEARCH
Bone-marrow-derived cells for cardiac stem cell therapy: safe or still under scrutiny?
Nature Clinical Practice Cardiovascular Medicine Article (01 Feb 2007)
Bone-marrow-derived cells for cardiac stem cell therapy: safe or still under scrutiny?
Nature Clinical Practice Cardiovascular Medicine Article (01 Feb 2007)
Experimental models for cardiac regeneration
Nature Clinical Practice Cardiovascular Medicine Article (01 Mar 2006)


